Validation/Evaluation of Multimodal Imaging Combining 3D Ultrasound and Stress Myocardial Scintigraphy in the Diagnosis of Coronary Artery Disease
Primary Purpose
Coronary Artery Disease, Coronary Disease
Status
Withdrawn
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Stress ultrasound
Scintigraphy
Coronary angiography
Sponsored by
About this trial
This is an interventional diagnostic trial for Coronary Artery Disease
Eligibility Criteria
Inclusion Criteria:
- The patient must have given his/her informed and signed consent
- The patient must be insured or beneficiary of a health insurance plan
- The patient has a documented coronaropathy
- The patient needs a new coronarography following symptoms indicating a change in his/her coronary disease state
Exclusion Criteria:
- The patient is participating in another study
- The patient is in an exclusion period determined by a previous study
- The patient is under judicial protection, under tutorship or curatorship
- The patient refuses to sign the consent
- It is impossible to correctly inform the patient
- The patient is pregnant
- The patient is breastfeeding
- Patients with arrhythmias, left bundle branch block on the electrocardiogram which would complicate the interpretation of examinations
- Unstable, acute coronary syndromes unstable needing emergency coronary angiography
- Patient with contraindication for conducting a stress test:
- poorly controlled hypertension
- pre-existing severe arrhythmia
- aortic stenosis
- and obstructive hypertrophic cardiomyopathy
- Patient has contraindication for atropine
- History of prostate adenoma
- Glaucoma
Sites / Locations
- Centre Hospitalier Universitaire de Nîmes
Arms of the Study
Arm 1
Arm 2
Arm Type
Other
Other
Arm Label
Severe coronary artery disease
Coronary artery disease
Arm Description
Patients in this group have coronary artery disease with a stenosis of >70%.
Patients in this group have coronary artery disease with stenosis < 70%.
Outcomes
Primary Outcome Measures
The difference between AUCs for multimodal imaging and scintigraphy
Secondary Outcome Measures
The difference between AUCs for multimodal imaging and stress ultrasound
Full Information
NCT ID
NCT01321970
First Posted
March 23, 2011
Last Updated
June 16, 2017
Sponsor
Centre Hospitalier Universitaire de Nīmes
1. Study Identification
Unique Protocol Identification Number
NCT01321970
Brief Title
Validation/Evaluation of Multimodal Imaging Combining 3D Ultrasound and Stress Myocardial Scintigraphy in the Diagnosis of Coronary Artery Disease
Official Title
Validation and Evaluation of Multimodal Imaging Combining Three-dimensional Ultrasound and Stress Myocardial Scintigraphy in the Diagnosis of Coronary Artery Disease
Study Type
Interventional
2. Study Status
Record Verification Date
March 2015
Overall Recruitment Status
Withdrawn
Why Stopped
Impossible to start to the study.
Study Start Date
June 2013 (Actual)
Primary Completion Date
December 2015 (Anticipated)
Study Completion Date
December 2015 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Centre Hospitalier Universitaire de Nīmes
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Our primary goal is to validate a new diagnostic tool for functional coronary artery stenosis that uses multimodal imaging (combining stress echocardiography and stress scintigraphy) in patients with known coronary chest pain.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Coronary Artery Disease, Coronary Disease
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
0 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Severe coronary artery disease
Arm Type
Other
Arm Description
Patients in this group have coronary artery disease with a stenosis of >70%.
Arm Title
Coronary artery disease
Arm Type
Other
Arm Description
Patients in this group have coronary artery disease with stenosis < 70%.
Intervention Type
Procedure
Intervention Name(s)
Stress ultrasound
Intervention Description
Qualitative interpretation of the left ventricular wall motion abnormalities is performed in real time in the resting phase and during pharmacological stress. The translation of quantitative data is then performed for each of the 17 segments on a bulls-eye pattern identical to that of scintigraphy.
Intervention Type
Procedure
Intervention Name(s)
Scintigraphy
Intervention Description
Image acquisition is synchronized to the electrocardiogram. The tomographic sections are represented in the 3 directions of space, the analysis is also done on the classical representation in 17 segments. (Typically used in ultrasound perfusion scintigraphy or PET).
Intervention Type
Procedure
Intervention Name(s)
Coronary angiography
Intervention Description
Performed in interventional cardiology setting using a guide introduced through the radial or femoral artery. The injection of iodine allows opacification of coronary arteries and their visualization by fluoroscopy. The qualitative interpretation of the data is translated in terms of percentage of stenosis of the coronary artery. It is thus considered that the stenosis is significant at over 70% obstruction of the lumenal diameter. This interpretation is made for each of the three main coronary arteries and their tributaries:
Right coronary (proximal, middle and distal) and collateral (inter ventricular posterior ventricular posterior retro)
Inter ventricular anterior (proximal, middle and distal) and its tributaries (diagonal and septal)
Circumflex (proximal, middle and distal) and collateral (first and second marginal)
Primary Outcome Measure Information:
Title
The difference between AUCs for multimodal imaging and scintigraphy
Time Frame
4 days
Secondary Outcome Measure Information:
Title
The difference between AUCs for multimodal imaging and stress ultrasound
Time Frame
4 days
10. Eligibility
Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
The patient must have given his/her informed and signed consent
The patient must be insured or beneficiary of a health insurance plan
The patient has a documented coronaropathy
The patient needs a new coronarography following symptoms indicating a change in his/her coronary disease state
Exclusion Criteria:
The patient is participating in another study
The patient is in an exclusion period determined by a previous study
The patient is under judicial protection, under tutorship or curatorship
The patient refuses to sign the consent
It is impossible to correctly inform the patient
The patient is pregnant
The patient is breastfeeding
Patients with arrhythmias, left bundle branch block on the electrocardiogram which would complicate the interpretation of examinations
Unstable, acute coronary syndromes unstable needing emergency coronary angiography
Patient with contraindication for conducting a stress test:
poorly controlled hypertension
pre-existing severe arrhythmia
aortic stenosis
and obstructive hypertrophic cardiomyopathy
Patient has contraindication for atropine
History of prostate adenoma
Glaucoma
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Madeleine Rubini, MD
Organizational Affiliation
Centre Hospitalier Universitaire de Nîmes
Official's Role
Principal Investigator
Facility Information:
Facility Name
Centre Hospitalier Universitaire de Nîmes
City
Nîmes Cedex 09
State/Province
Gard
ZIP/Postal Code
30029
Country
France
12. IPD Sharing Statement
Learn more about this trial
Validation/Evaluation of Multimodal Imaging Combining 3D Ultrasound and Stress Myocardial Scintigraphy in the Diagnosis of Coronary Artery Disease
We'll reach out to this number within 24 hrs